Consider This Before Taking a Position in BRO

Shares of Financial Services sector company Brown & Brown moved -4.5% today, and are now trading at a price of $59.2. The large-cap stock's daily volume was 1,192,530 compared to its average volume of 1,242,134. The S&P 500 index returned a -0.3% performance.

Brown & Brown, Inc. markets and sells insurance products and services in the United States, Bermuda, Canada, Ireland, the United Kingdom, and the Cayman Islands. The company is based in Daytona Beach and has 12,023 full time employees. Its market capitalization is $16,766,743,552. Brown & Brown currently offers its equity investors a dividend that yields 0.7% per year.

10 analysts are following Brown & Brown and have set target prices ranging from $60 to $70 per share. On average, they have given the company a rating of buy. At today's prices, BRO is trading -9.89% away from its average analyst target price of $65.7 per share.

Over the last year, BRO shares have gone down by -3.8%, which represents a difference of 3.9% when compared to the S&P 500. The stock's 52 week high is $74 per share and its 52 week low is $52.91. With average free cash flows of $717,814,333.3 that have been growing at an average rate of 22.7% over the last four years, Brown & Brown declining stock performance may not be reflective of the quality of its underlying business.

Date Reported Cash Flow from Operations ($ MM) Capital expenditures ($ MM) Free Cash Flow ($ MM) YoY Growth (%)
2021-12-31 942 -45 897 37.86
2020-12-31 722 -71 651 7.58
2019-12-31 678 -73 605 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.